Зміни глікемії під впливом цукрознижувальних засобів у щурів зі стрептозотоциновим діабетом на тлі висококалорійної дієти

О. П. Кіхтяк

doi:10.24026/1818-1384.1(34).2011.86138

Автор(и)

О. П. Кіхтяк Львівський національний медичний університет імені Данила Галицького, Львів, Ukraine

DOI:

https://doi.org/10.24026/1818-1384.1(34).2011.86138

Ключові слова:

Streptozotocin, Fat-Fed diet, insulin resistance, Metformin, Pioglitazone, Glimepiride

Анотація

Effects of sensitizers (Metformin, Pioglitazone) and stimulator of insulin secretion (Glimepiride) in Fat-Fed Streptozotocin rats were studied. It was discovered that Metformin in dose of 500 mg/kg and Pioglitazone in dose of 30 mg/kg in comparison with Glimepiride in dose of 1 mg/kg per day affect carbohydrate metabolism in Fat-Fed Streptozotocin male Wistar rats. Metformin decreases fasting glucose level, and Pioglitazone more than Metformin is able to descent HbA1c in compare with the control group. Fat-Fed Streptozotocin model which supposes insulin resistance proves high affectivity of sensitizers.

Біографія автора

О. П. Кіхтяк, Львівський національний медичний університет імені Данила Галицького, Львів

О.П. Кихтяк

Посилання

Данилова Л.А., Лопатина Н.И. Колориметрический метод определения гликозилированных гемоглобинов. // Лаб. дело. – 1986. – №5. – С. 281-283.

Atkinson L.L., VcDonald-Dyck C., Benkoczi C., Finegood D.T. Effect of chronic rosiglitazone, metformin and glyburide treatment on beta-cell mass, function and insulin sensitivity in mZDF rats. // Diabetes Obes Metab. – 2008. – Vol. 10, №9. – P. 780-790. https://doi.org/10.1111/j.1463-1326.2007.00811.x

Bailey C.J., Bagdonas A., Rubes J, McMorn S.O., Donaldson J., Biswas N., Stewart M.W. Rosiglitasone/metformin fixed-dose combination compared with uptitrated metformin alone in type 2 diabetes mellitus: a 24-week, multicenter, randomized, double-blind, parallel-group study // Clin. Ther. – 2005. – Vol. 27(10). – P. 1548-1561. https://doi.org/10.1016/j.clinthera.2005.10.012

Cheng J.T., Huang C.C., Liu I.M, Tzeng T.F., Chang C.J. Novel Mechanism for Plasma Glucose-Lowering Action of Metformin in Streptozotocin-Induced Diabetic Rats // Diabetes. – 2006. – Vol. 55. – P. 819-825. https://doi.org/10.2337/diabetes.55.03.06.db05-0934

Costa S., Goncales A., Areas A. Morgabel R.G. Effects of Metformin on QT and QTc Interval Dispersion of Diabetic Rats // Arq. Bras. Cardiol. – 2008. – Vol. 90(4). – P. 254-260. https://doi.org/10.1590/s0066-782x2008000400004

Gaikwad A.B., Viswanad B., Ramarao P. PPAR gamma agonists partially restores hyperglycemia induced aggravation of vascular dysfunction to angiotensin II in thoracic aorta isolated from rats with insulin resistance // Pharmacol. Res. – 2007. – Vol. 55(5). – P. 400-407. https://doi.org/10.1016/j.phrs.2007.01.015

Larsen P.J., Jensen P., Sorensen R.V. Differential influences of peroxisome proliferators-activated receptors gamma and alpha on food intake and energy homeostasis // Diabetes. – 2003. – Vol. 52(9). – P. 2249-2259. https://doi.org/10.2337/diabetes.52.9.2249

Matsumoto T., Noguchi E., Ishida K., Kobayashi T., Yamada N., Kamata K. Metformin normalizes endothelial function by suppressing vasoconstrictor prostanoids in mesenteric arteries from OLETF rats, a model of Type 2 diabetes // Am. J. Physiol. Heart Circ. – 2008. – Vol. 18. – P. 112-118. https://doi.org/10.1152/ajpheart.00486.2008

Matsumoto T., Noguchi E., Kobayashi T., Kamata K. Mechanism underlying the chronic pioglitazone treatment-induced improvement in the impaired endothelium-dependent relaxation seen in aortas from diabetic rats // Free Radic. Biol. Med. – 2007. – Vol. 42(7). – P. 993-1007. https://doi.org/10.1016/j.freeradbiomed.2006.12.028

Matsuura K., Mori Y., Kitahara Y., Miura K., Mine T., Tajima N. Differences in insulin secretion in portal blood following acute administration of glimepiride and glibenclamide: a study in OLETF rats // Diabetes. – 2003. – Vol. 52, Suppl. 1. – P. A126.

Mori Y., Ojima K., Fujimori Y., Aoyagi I., Kusama H., Yamazaki Y., Kojima S., Shibata N., Itoh Y., Tajima N. Effects of mitiglinide on glucose-induced insulin release into the portal vein and fat-induced triglyceride elevation in prediabetic and diabetic OLEFT rats // Endocrine. – 2006. – Vol. 29(2). – P.309-315. https://doi.org/10.1385/endo:29:2:309

Okamoto T., Kanemoto N., Ohbuchi Y. Characterization of STZ-induced Type 2 Diabetes in Zucker Fatty Rats // Exp. Anim. – 2008. – Vol. 57(4). – P. 335-345. https://doi.org/10.1538/expanim.57.335

Pathan A.R., Viswanad B., Sonkusare S.K., Ramarao P. Chronic administration of pioglitazone attenuates intracerebroventricular streptozotocin induced-memory impairment in rats // Life Sci. – 2006. – Vol. 79(23) – P. 2209-2216. https://doi.org/10.1016/j.lfs.2006.07.018

Reed M.J., Meszaros K., Entes L.J., Claypool M.D., Pinkett J.G., Gadbois T.M., Reaven G.M. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat // Metabolism. – 2000. – Vol. 49(11). – P. 1390-1394. https://doi.org/10.1053/meta.2000.17721

Srinivasan K., Viswanad B., Asrat L, Kaul C.L., Ramarao P. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening // Pharmacol. Res. – 2005. – Vol. 52(4). – P. 313-320. https://doi.org/10.1016/j.phrs.2005.05.004

Tessary P., Tiengo A. Metformin treatment of rats with diet-induced overweight and hypertriglyceridemia decreases plasma triglyceride concentration, while decreasing triglyceride and increasing ketone body output by the isolated perfused liver // Acta Diabetol. – 2008. – Vol. 45. – P. 143-145. https://doi.org/10.1007/s00592-008-0032-0

Verma S., Yao L., Dumont A.S., McNeill J.H. Metformin treatment corrects vascular insulin resistance in hypertension // Lippincott Williams & Wilkins. – 2000. – Vol. 18(10). – P. 1445-1450. https://doi.org/10.1097/00004872-200018100-00012

Waisundara V.Y., Hsu A., Huang D., Tan B.K. Scutellaria baicalensis Enhances the Anti-Diabetic Activity of Metfomin in Streptozotocin-Induced Diabetic Wistar rats // Am. J. Clin. Med. – 2008. – Vol. 36(3). – P. 517-540. https://doi.org/10.1142/s0192415x08005953

Yajima K., Shimada A., Hirose H., Kasuga A., Saruta T. "Low dose" metformin improves hyperglycemia better than acarbose in type 2 diabetics // The Review of Diabetic Studies. – 2004. – Vol. 1, №2. – P. 89-94. https://doi.org/10.1900/rds.2004.1.89